panaxadiol has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Feng, J; Ge, Y; Guan, F; Han, H; Lv, Y; Xu, M; Yang, X; Zhang, M; Zhang, Y; Zhao, J; Zhao, T | 1 |
| An, L; Du, P; Han, X; Jiang, S; Li, H; Li, J; Ren, D; Xu, G; Yuan, G | 1 |
2 other study(ies) available for panaxadiol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
(20R)-Panaxadiol as a Natural Active Component with Anti-Obesity Effects on ob/ob Mice via Modulating the Gut Microbiota.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Gastrointestinal Microbiome; Ginsenosides; Mice; Mice, Inbred C57BL; Obesity; Panax; RNA, Ribosomal, 16S | 2022 |
Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Ginsenosides; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Molecular Structure; Panax; Plant Roots; Rats; Rats, Wistar; Signal Transduction; Streptozocin | 2014 |